Reactome | IL37(?-218) binds SMAD3

IL37(?-218) binds SMAD3

Stable Identifier

R-HSA-9008692

Type

Reaction [binding]

Species

Homo sapiens

Compartment

cytosol

Synonyms

IL-37(?-218) binds SMAD3

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Interleukins (IL) are immunomodulatory proteins that elicit a wide array of responses in cells and tissues. Interleukin 37 (IL-37, IL-1 F7) is a member of the IL-1 family. There are five isoforms of IL-37 (a-e) of which transcript IL-37b is known to be functional (Sharma et al. 2008). This isoform is represented in UniProt as the canonical form of IL-37 and in Reactome as the full length, unprocessed form of IL-37. Like several other IL-1 family members, IL-37 is synthesized as a precursor that requires processing (primarily by caspase 1) to attain full receptor agonist or antagonist function. The putative caspase 1 cleavage site is at aspartic acid 20 (Kumar et al. 2002). Mothers against decapentaplegic homolog 3 (SMAD3) binds SMAD4 and this complex modulates the transcription of several genes downstream. IL-37(? 218) can bind SMAD3 (Nold M F et al. 2010, Grimsby S et al. 2004) and may affect its function.

Literature References

PubMed ID	Title	Journal	Year
20935647	IL-37 is a fundamental inhibitor of innate immunity Dinarello, CA, Bufler, P, Nold, MF, Nold-Petry, CA, Palmer, BE, Zepp, JA	Nat. Immunol.	2010
15527767	Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity Jaensson, H, Souchelnytskyi, S, Lomnytska, M, Hellman, U, Dubrovska, A, Grimsby, S	FEBS Lett.	2004